Akebia Therapeutics Inc. buy mixitrader
Start price
16.03.24
/
50%
€1.51
Target price
16.03.25
€2.00
Performance (%)
2.26%
End price
30.03.24
€1.54
Summary
This prediction ended on 30.03.24 with a price of €1.54. With a performance of 2.26%, the BUY prediction by mixitrader for Akebia Therapeutics Inc. closed with a slight gain. mixitrader has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -1.887% | -1.887% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to mixitrader what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Below average Management
Bad culture
Little innovation
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Business model of the past or high risk
Probably not worthwhile Investment
High valuation
Bad rating
Little Investments for future growth
Risky balance sheet
Increased challenges to pay loans and raise capital
Few uniques
negative Cash Flow expected
ROE lower than 10% per year
Significant cyclical dependencies
Little known brand
Comments by mixitrader for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
In the thread Trading Akebia Therapeutics Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.